Grindr is ramping up its focus on healthcare with plans to acquire PurposeMed Inc., the parent company of telehealth provider Freddie.
Freddie provides access to HIV prevention and PrEP care through telehealth visits. Grindr plans to pick up PurposeMed for $250 million in cash and stock, consisting of $190 million in cash and $60 million in Grindr common stock.
The agreement also includes the potential for up to $70 million in additional cash consideration tied to 2027 performance targets, payable in 2028. The companies expect the deal to close in the fourth quarter, subject to applicable closing conditions.
Freddie expects to generate 2026 revenue of more than $80 million and more than $10 million in Adjusted EBITDA.
Executives say the transaction marks the “first major acquisition” since its founding and a “significant step in building out the Global Gayborhood,” leading with Grindr Health. The acquisition underscores the company's ambition to evolve beyond dating and expand into health and wellness.
With the addition of Freddie, Grindr will make it easier for millions of users to learn about PrEP, connect with clinicians, access testing and prescriptions, and receive medication through the Grindr app, the company said.
Grindr says the deal advances its commitment to connect 10 million LGBTQ+ people globally to HIV prevention directly through the app by 2028.
"For generations of gay men, HIV shaped how we thought about intimacy, relationships and our own futures. Today, we have the tools to prevent it. New infections should be close to zero, and that is what we are striving to achieve,” George Arison, Grindr CEO and chairperson, said in a statement.
Source link







